Search

Your search keyword '"Ananta Shreshtha"' showing total 2 results
Start Over Author "Ananta Shreshtha" Topic budd-chiari syndrome
2 results on '"Ananta Shreshtha"'

1. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

Author

Ian Homer Y. Cua, Chhagan Bihari, Cosmas Rinaldi A Lesmana, Hemant Deshmukh, CE Eapen, Zaigham Abbas, Shiv Kumar Sarin, Valérie Paradis, Mamun Al Meshtab, Yasuhiko Sugawara, Roongruedee Chaiteeraki, Amar Mukund, Guohong Han, Xingshun Qi, Suprabhat Giri, Masayoshi Kage, Sundeep Punamiya, Ananta Shreshtha, Sombat Treeprasertsuk, and Akash Shukla

Subjects
medicine.medical_specialty, Hepatology, medicine.diagnostic_test, business.industry, medicine.disease, Thrombosis, Inferior vena cava, medicine.anatomical_structure, medicine.vein, Internal medicine, Liver biopsy, Ascites, cardiovascular system, medicine, Budd–Chiari syndrome, Portal hypertension, Radiology, medicine.symptom, business, Vein
Abstract

Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific region. The hepatic vein ostial stenosis and short segment thrombosis are common in some parts of Asia-Pacific region, while membranous obstruction of the vena cava is common in some and complete thrombosis of hepatic veins in others. Prevalence of myeloproliferative neoplasms and other thrombophilic disorders in BCS varies from region to region and with different sites of obstruction. This heterogeneity also raises several issues and dilemmas in evaluation and approach to management of a patient with BCS. The opportunity to recanalize hepatic vein in patients with hepatic vein ostial stenosis or inferior vena cava stenting or pasty among those membranous obstruction of the vena cava is a unique opportunity in the Asia-Pacific region to restore hepatic outflow closely mimicking physiology. In order to address these issues arising out of the diversity as well as the unique features in the region, the Asia Pacific Association for Study of Liver has formulated these guidelines for clinicians.

Published
2021
Full Text
View/download PDF

2. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)

Author

Akash, Shukla, Ananta, Shreshtha, Amar, Mukund, Chhagan, Bihari, C E, Eapen, Guohong, Han, Hemant, Deshmukh, Ian Homer Y, Cua, Cosmas Rinaldi Adithya, Lesmana, Mamun, Al Meshtab, Masayoshi, Kage, Roongruedee, Chaiteeraki, Sombat, Treeprasertsuk, Suprabhat, Giri, Sundeep, Punamiya, Valerie, Paradis, Xingshun, Qi, Yasuhiko, Sugawara, Zaigham, Abbas, and Shiv Kumar, Sarin

Subjects
Consensus, Humans, Vena Cava, Inferior, Budd-Chiari Syndrome, Hepatic Veins
Abstract

Budd Chiari syndrome (BCS) is a diverse disease with regard to the site of obstruction, the predisposing thrombophilic disorders and clinical presentation across the Asia-Pacific region. The hepatic vein ostial stenosis and short segment thrombosis are common in some parts of Asia-Pacific region, while membranous obstruction of the vena cava is common in some and complete thrombosis of hepatic veins in others. Prevalence of myeloproliferative neoplasms and other thrombophilic disorders in BCS varies from region to region and with different sites of obstruction. This heterogeneity also raises several issues and dilemmas in evaluation and approach to management of a patient with BCS. The opportunity to recanalize hepatic vein in patients with hepatic vein ostial stenosis or inferior vena cava stenting or pasty among those membranous obstruction of the vena cava is a unique opportunity in the Asia-Pacific region to restore hepatic outflow closely mimicking physiology. In order to address these issues arising out of the diversity as well as the unique features in the region, the Asia Pacific Association for Study of Liver has formulated these guidelines for clinicians.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results